+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

EMS SA - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 27 Pages
  • May 2023
  • GlobalData
  • ID: 4392833
EMS SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.


  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - The publisher's summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.


EMS SA (EMS), a subsidiary of Grupo NC, is a pharmaceutical company that focuses on the development of products for the improvement of the health and well-being of the population. The company operates in the segments of medical prescription, generics, branded pharmaceuticals, manufacturing products, OTC, and hospitals. Its major product portfolio includes drugs in the therapeutic areas of anti-inflammatories, analgesics, antihypertensives, anthelmintics, antidiabetics, antibiotics, anti-ulcers, topical corticosteroids, and anti-flu. EMS has production units in Sao Bernardo do Campo, Jaguariuna and Hortolandia in Sao Paulo; Novamed, Manaus in Amazonas; and Brasilia in Federal District. The company is certified by European Medicines Agency. EMS is headquartered in Hortolandia, Brazil.

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with the publisher's detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • EMS SA - Key Facts
  • EMS SA - Key Employees
  • EMS SA - Key Operational Employees
  • EMS SA - Major Products and Services
  • EMS SA - History
  • EMS SA - Company Statement
  • EMS SA - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • EMS SA - Business Description
  • EMS SA - Corporate Strategy
  • EMS SA - SWOT Analysis
  • SWOT Analysis - Overview
  • EMS SA - Strengths
  • EMS SA - Weaknesses
  • EMS SA - Opportunities
  • EMS SA - Threats
  • EMS SA - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • EMS SA, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • EMS SA, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • EMS SA, Recent Deals Summary
Section 4 - Appendix
  • Methodology
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • EMS SA, Key Facts
  • EMS SA, Key Employees
  • EMS SA, Key Operational Employees
  • EMS SA, Major Products and Services
  • EMS SA, History
  • EMS SA, Other Locations
  • EMS SA, Subsidiaries
  • EMS SA, Joint Venture
  • EMS SA, Key Competitors
  • EMS SA, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • EMS SA, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • EMS SA, Recent Deals Summary
List of Figures
  • EMS SA, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • EMS SA, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023



Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Ache Laboratorios Farmaceuticos SA
  • Biotecnica Industria E Comercio Ltda
  • Laboratorio Teuto Brasileiro SA
  • moksha8 Pharmaceuticals Inc
  • Eurofarma Laboratorios SA
  • Intrials Research Clinical.